Regulation of Syk Expression in Human Basophils
Regulation of Syk Expression in Human Basophils
批准号:
10276240
负责人:
Donald W MacGlashan
金额:
$40.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-19 至 2025-05-31
关键词:
AddressAffectAllergic ReactionAntibodiesB-LymphocytesBasophilsBehaviorBindingBiological Response Modifier TherapyBloodBlood specimenCD34 geneCellsClinicClinicalConsentDataElementsEventFamilyFeedbackGene ExpressionGenerationsGeneticGenetic PolymorphismGenetic TranscriptionGenotypeHeterogeneityHistamine ReleaseHumanHypersensitivityIgEIgE ReceptorsImmediate hypersensitivityIndividualInternationalLaboratoriesLeukocytesLinkLinkage DisequilibriumMediatingModelingObservational StudyOrganPathway interactionsPatientsPhosphotransferasesPilot ProjectsPopulationPromoter RegionsProtein Tyrosine KinaseProteinsReactionRegulationRegulatory PathwayReportingRodentSNP genotypingSYK geneSamplingSignal PathwaySignal TransductionTestingTissuesanti-IgEbasecell typeclinical efficacycytokinemRNA Differential Displaysmast cellomalizumabperipheral bloodprogramspromoterreceptorresponsetranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Immediate hypersensitivity reactions are dependent on IgE-mediated activation of
basophils and mast cells. There are many elements that regulate expression of the
response that distribute up and down the cascade of events from the generation of IgE
to the tissue end-organ response and the positive and negative feedback loops that link
the various elements together. One of the early necessary elements is related to the
intrinsic ability of the basophil and mast cell to respond to aggregation of the IgE
receptor. It is now apparent that for human basophils, this intrinsic responsiveness
primarily relates the expression of one of the early receptor associated kinases, SYK.
Several studies have established that SYK activity is likely a rate-limiting step in the IgE-
dependent signal transduction cascade and expression levels determine its activity.
Studies have also demonstrated that the very low expression levels of SYK in basophils
are unique to this leukocyte. Recent studies demonstrate 5 regulatory pathways of SYK
expression, two of which have recently been excluded for further consideration as an
explanation for the natural heterogeneity of expression in the population. Based on
preliminary results, the application proposes to examine one of newly described
pathways in greater detail. A large international study established the association of a
SNP family in the SYK gene promoter, in 100% linkage disequilibrium, with SYK
expression is multiple cell types. In a pilot study we found that the same SNP family
strongly associates with the magnitude of IgE-mediated secretion. Aim 1 of the proposal
will expand in both size and detail the pilot study observations. Aim 2 will address a
question raised by the possible association of genotype with function, the reversal of
suppressed SYK expression in patients with omalizumab. Aim 3 will determine which
SNP is relevant to SYK gene expression and examine several hypotheses regarding the
transcription factors that modulate the effect.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Syk Expression in Human Basophils
-
批准号:10434940
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2021
-
负责人:Donald W MacGlashan
-
依托单位:
Regulation of Syk Expression in Human Basophils
-
批准号:10633098
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2021
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8628227
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8810641
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Donald W MacGlashan
-
依托单位:
Human Basophil Phenotypes and Therapeutic Outcomes
-
批准号:8707080
-
项目类别:
-
资助金额:$44.47万
-
财政年份:2013
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8482055
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2012
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7914972
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2009
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7134190
-
项目类别:
-
资助金额:$111.7万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
FcERI Expression, Cellular Sensitivity, In vivo Response
-
批准号:7150225
-
项目类别:
-
资助金额:$24.62万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Administration
-
批准号:7150230
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7487023
-
项目类别:
-
资助金额:$113.08万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7666139
-
项目类别:
-
资助金额:$116.43万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7901048
-
项目类别:
-
资助金额:$118.68万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7263974
-
项目类别:
-
资助金额:$111.96万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:2451108
-
项目类别:
-
资助金额:$20.77万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:6149865
-
项目类别:
-
资助金额:$22.0万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:2871563
-
项目类别:
-
资助金额:$21.26万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129810
-
项目类别:
-
资助金额:$14.99万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129817
-
项目类别:
-
资助金额:$15.54万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129814
-
项目类别:
-
资助金额:$13.18万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
海外基金